CD8A and vitiligo: Our results suggest that vitiligo patients’ autologous melanocytes transplantation efficiency may be predicted by perilesional skin-homing CD8+ T cell activities, and the immuneregulatory DMSCs might be used as auxiliary agent to improve the efficacy.